Skelding, Kathryn A.; Rostas, John A. P.; Verrills, Nicole M. "Controlling the cell cycle: the role of calcium/calmodulin-stimulated protein kinases I and II". Originally published in Cell Cycle Vol. 10, Issue 4, p. 631-639 (2011) and is regulated by multi-site phosphorylation and targeting. Using pharmacological inhibitors that were believed to be specific for CaMKII, CaMKII has been implicated in every phase of the cell cycle. However, these 'specific' inhibitors also produce effects on other CaMKs. These additional effects are usually ignored, and the effects of the inhibitors are normally attributed to CaMKII without further investigation.
INTRODUCTION
The generation of new cells from existing cells is a fundamental requirement for all living organisms. A cell reproduces via an orderly sequence of events, known as the cell cycle, which is classified into several distinct phases in mammalian cells ( Figure   1 ). The first phase is Interphase, and is comprised of G1 (Gap/Growth Phase 1), S (DNA replication), and G2 (Gap/Growth Phase 2). The second phase is M Phase, which consists of Mitosis (prophase, prometaphase, metaphase, anaphase, telophase).
The cell finishes dividing by undergoing Cytokinesis (separation of the daughter cell from the parent cell). Each phase of the cell cycle is tightly controlled by a network of regulatory proteins, and transition from one stage to the next is regulated by a number of events known as checkpoints. Entry and exit from these checkpoints is largely controlled by the cyclin-dependent kinases (CDK) and their associated cyclin proteins 1 . Understanding precisely how various cell cycle control mechanisms are regulated has important implications for the treatment of proliferative diseases, such as cancer.
Figure 1
This review investigates the role of a family of protein kinases -the multifunctional Serine (S)/Threonine (T) Ca 2+ /calmodulin (CaM) stimulated protein kinases (CaMK)
-in regulating the cell cycle. One member of this family, CaMKII, has been implicated as a regulator of every phase of the cell cycle ( Figure 1 ). There is some controversy regarding its role, and the aim of this review is to identify the factors that account for this controversy and to clarify the role of CaMKII and other CaMK family members in controlling the cell cycle.
CALCIUM, CALMODULIN, AND THE CELL CYCLE
Studies over several decades have implicated Ca 2+ as a regulator of a variety of cellular functions, including cell cycle progression, and many reviews have highlighted the important role that Ca 2+ plays in regulating cellular proliferation, fertilisation, and early development [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] . Ca 2+ plays an important role throughout the cell cycle, and has been implicated in the regulation of the G1/S and G2/M transitions, as well as the metaphase-anaphase transition 6, 8 .
CaM is a small 16.7 kDa protein, and is one of the major Ca 2+ sensors in eukaryotes.
CaM has also been implicated in the regulation of the cell cycle. Progression through G1 (specifically the G1/S transition) and exit from mitosis are sensitive to changes in 15 . However, CaMKII does not possess an activation loop. Thus, while the CaMK family possess many similarities, there are some fundamental differences in the structure and regulation of these kinases (Table 1 ). 16 . Phosphorylation of the conserved T (T174 to T180, depending on the isoform) in the activation loop by CaMKK is required for maximal CaMKI activity 17 , although this depends on the substrate 18 , which suggests that CaMKI may also be regulated by targeting. Some isoforms of CaMKI have been shown to translocate once they become activated 19, 20 , suggesting that molecular targeting may play a role in the regulation of CaMKI function, however, this remains to be determined. Furthermore, the effects of phosphorylation at T177 on targeting of CaMKI have not been examined. CaMKI has been implicated in a variety of cellular functions, including the control of synapsin in nerve terminals 21 , growth cone motility and axon outgrowth 22 , the cystic fibrosis transmembrane regulator 23 , aldosterone synthase expression 24 , and the cell cycle 25, 26 .
Figure 2

CaMKIV
CaMKIV is encoded by one gene (α), which produces at least one splice variant (β). 35 , and cell cycle control 25 .
CaMKK
CaMKK is encoded by two genes (1 and 2) that encode CaMKKα and CaMKKβ, respectively. The CaMKK2 gene produces several splice isoforms 36 . CaMKK require Ca 2+ /CaM for maximal activity 37 , and can also undergo autophosphorylation 38 . Autophosphorylation, however, does not seem to alter kinase activity 38 . All
CaMKKs are monomeric, and are between 54 and 68 kDa in size. CaMKK is primarily expressed in the brain, but is also present in the thymus, spleen, and testis [28] [29] [30] [31] . CaMKKs phosphorylate CaMKI and CaMKIV, but they can also phoshorylate other substrates, such as AMP activated protein kinase (AMPK) 39 .
CaMKII
CaMKII is encoded by four genes (α, β, γ, and δ) 40 [41] [42] [43] [44] [45] [46] . Non-neuronal
CaMKII has been implicated in the regulation of other biological processes, such as fertilisation 4 , osteogenic differentiation 47 , the maintenance of vascular tone 48 , and cell proliferation 49 .
The fact that CaMKII is ubiquitously expressed raises the question of how a widely expressed kinase can produce such varied cell-specific responses. The answer lies in its unique regulatory mechanisms, the subtlety of which has only recently been appreciated.
Regulation of CaMKII
The biological properties of CaMKII are regulated by multi-site phosphorylation and targeting to specific subcellular locations through interactions with other proteins.
These two control mechanisms can also influence one another, as the interaction between CaMKII and some binding partners can be modified by the phosphorylation state of the kinase, as well as by phosphorylation of the binding partner 49 .
Phosphorylation at the well-characterized CaMKII phosphorylation sites, T286 and the paired sites T305/306 (numbered for the CaMKIIα isoform), directly alters Emerging evidence from several laboratories shows that the behaviour of CaMKII in vivo cannot always be predicted from our understanding of its behaviour in vitro, 
INHIBITORS OF CaMKII
Interpretation of previous studies relies on the use of pharmacological inhibitors as well as expression of constitutively active or kinase dead mutants of CaMKII, or other members of the CaMK family.
The most widely used small molecular CaMKII inhibitors are 1- 
CaMK REGULATION OF THE CELL CYCLE
Studies in many cell types using a variety of approaches 49, have established that the CaMK family are important regulators of the cell cycle and that they are involved in every phase of the cell cycle ( Table 2) . Many of these studies have concluded that
CaMKII controls the observed effects based on the action of the 'CaMKII specific inhibitors' KN-62 and KN-93 ( Figure 1 ). However, due to the reasons outlined above, these conclusions need further examination. 89 . In addition, hCaMKIINβ overexpression decreased ovarian cancer cell growth and tumorigenicity 93 . These findings provide the strongest evidence supporting a role of CaMKII in the control of S phase progression. However, whether the functions controlled by CaMKII in S phase are regulated by the endogenous CaMKII inhibitor, CaMKIIN, or by another regulatory mechanism remains to be seen.
G2 Phase and Mitosis
Mitotic Entry
The strongest evidence indicating that CaMKII plays a role in cell cycle regulation is the wealth of data in a variety of cell lines using numerous methods that demonstrate that CaMKII function is essential for progression through the G2 and M phases of the cell cycle 64 49 .
By contrast, Planas-Silva and Means 75 showed that overexpression of a constitutively active truncated mutant blocked cells in the G2 phase of the cell cycle. This is the only study that appears to contradict the wealth of evidence demonstrating that 
Metaphase-Anaphase Transition
Further compelling evidence supporting the role of CaMKII in mitotic progression has come from elegant studies examining egg activation. 70, 96 . This data strongly indicates that CaMKII is essential for progression through mitosis, and specifically, the metaphase-anaphase transition.
CaMKII Regulation of the Mitosis Promoting Factor (MPF)
The key mediator of the G2/M transition in eukaryotic cells is thought to be the mitosis promoting factor (MPF), a complex formed by Cdk1 (also known as Cdc2) and cyclin B 100 . During interphase, the MPF is inhibited by Cdk1 phosphorylation at two sites, T14 and Tyrosine (Y) 15. The kinases Myt1 and Wee1 are believed to be responsible for this inhibitory phosphorylation. At the G2/M transition, these phosphorylations are reversed by the Cdc25C checkpoint phosphatase, leading to MPF activation and mitosis 101 . During interphase, Cdc25C is inhibited by S216 phosphorylation, and CaMKII is one of a number of kinases that has been reported to phosphorylate this site 102 . Therefore, CaMKII would act as an inhibitor of mitosis.
Cdc25C, however, can also be phosphorylated at a number of activating sites 103, 104 .
CaMKII also phosphorylates these activating sites 73 , hence acting as a positive regulator of mitosis. This raises the question of how such opposing effects of CaMKII can be regulated in vivo. One possibility is differential molecular targeting.
If CaMKII is phosphorylated at different sites throughout the cell cycle, this would alter the proteins with which it interacts, thereby targeting it to different molecular complexes and allowing it to both positively and negatively regulate mitosis. Indeed, that full length CaMKII promotes cell proliferation 49 , whilst truncated 75 or T253 phospho-mimic 49 mutants inhibit proliferation, strongly support this hypothesis.
Role of CaMKII in Regulating Microtubule Dynamics
Microtubules are composed of α-and β-tubulin heterodimers which assemble with microtubule-associated proteins (MAPs) to form polymeric filaments 105 .
Microtubules are dynamic structures that are constantly growing and shortening, and their ends have the ability to switch stochastically between these states, in a phenomenon termed dynamic instability 106 . Microtubule growth can be interrupted by a random transition in depolymerisation, called a catastrophe, a process that is essential for the metaphase-anaphase transition 107 . The dynamic instability of microtubules is crucial for many microtubule-dependent processes, but it is most important in mitosis.
CaMKII is a dynamic component of the mitotic apparatus, and is essential for initial centrosome duplication 108 . During interphase, CaMKII is localized diffusely in the cytoplasm and nucleus. At metaphase, CaMKII is associated on the spindle poles, and at the metaphase-anaphase transition it is localized to the centrosomes and between the spindle poles. 
CONCLUSIONS
Understanding how the cell cycle is regulated is one of the fundamental pursuits of cell biology. At least one member of the CaMK family has been implicated in each phase of the cell cycle, however, exactly how they regulate these phases is currently 
